Antiphospholipid syndrome (APS) is characterized by the presence of recurrent venous/ arterial thrombosis and fetal losses associated with a family of auto-antibodies directed against phospholipid (PL)-binding proteins. Among them, β2 glycoprotein I (β2GPI) is the most important. As a plasma cationic protein, β2GPI binds to anionic PLs involved in several fluid-phase coagulation steps, and more importantly, it can be expressed on the surface of different cell types. Anti-β2GPI antibodies recognize the molecule expressed on endothelial cells, platelets, monocytes, and trophoblast cells. Once bound, the antibodies trigger in vitro cell signaling that modulates biological responses potentially responsible for pathogenic mechanisms. Experimental animal models have supported the in vivo pathogenic role of anti-β2GPI antibodies in both thrombosis and fetal loss models.

Role of Anti-beta2 Glycoprotein I Antibodies in Antiphospholipid Syndrome: In Vitro and In Vivo Studies / Meroni, Pl; Ronda, Nicoletta; DE ANGELIS, V; Grossi, C; Raschi, E; Borghi, Mo. - In: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. - ISSN 1080-0549. - 32:1(2007), pp. 67-73. [10.1007/s12016-007-0021-z]

Role of Anti-beta2 Glycoprotein I Antibodies in Antiphospholipid Syndrome: In Vitro and In Vivo Studies.

RONDA, Nicoletta;
2007-01-01

Abstract

Antiphospholipid syndrome (APS) is characterized by the presence of recurrent venous/ arterial thrombosis and fetal losses associated with a family of auto-antibodies directed against phospholipid (PL)-binding proteins. Among them, β2 glycoprotein I (β2GPI) is the most important. As a plasma cationic protein, β2GPI binds to anionic PLs involved in several fluid-phase coagulation steps, and more importantly, it can be expressed on the surface of different cell types. Anti-β2GPI antibodies recognize the molecule expressed on endothelial cells, platelets, monocytes, and trophoblast cells. Once bound, the antibodies trigger in vitro cell signaling that modulates biological responses potentially responsible for pathogenic mechanisms. Experimental animal models have supported the in vivo pathogenic role of anti-β2GPI antibodies in both thrombosis and fetal loss models.
2007
Role of Anti-beta2 Glycoprotein I Antibodies in Antiphospholipid Syndrome: In Vitro and In Vivo Studies / Meroni, Pl; Ronda, Nicoletta; DE ANGELIS, V; Grossi, C; Raschi, E; Borghi, Mo. - In: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. - ISSN 1080-0549. - 32:1(2007), pp. 67-73. [10.1007/s12016-007-0021-z]
File in questo prodotto:
File Dimensione Formato  
Rev. b2GPI 2007.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 79.57 kB
Formato Adobe PDF
79.57 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1630628
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 20
social impact